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he Ethnic Rosetta Stone
ranslating Risk Factors,
laque Scores, and Mortality*
ohn A. Rumberger, PHD, MD, FACC
olumbus, Ohio; and Princeton, New Jersey
he discovery of the Rosetta stone in 1799 by Napoleon’s
orces digging a fort in el-Rashid (Rosetta) had a profound
mpact on translating the lost Egyptian language of hiero-
lyphics into Greek, a more easily comprehended modern-
ay language.
Translating population-based cardiovascular (CV) risk
actors into individual preventive care paradigms is often
ike looking at hieroglyphics—to date there are hundreds of
actors that can influence personal CV risk, and more appear
n the published literature each year. Calculating a Framing-
am risk point score (1) is a common initial approach to
ranslating these variable factors into an estimation of global
V risk. However, in point of fact, this scoring system
erely defines the median risk for a population of similar
otal point scores, meaning that 50% of the same group is at
higher personal risk and 50% of the same group is at a
ower personal risk. This is a partial, but incomplete,
ranslation.
See page 953
Coronary artery calcification (CAC) quantification (calcium
core) using noncontrast computed tomography has been
hown in clinical and pathological studies to provide an
estimation” (partial translation) of the atherosclerotic plaque
urden (2–4); furthermore, it has been shown in clinical
tudies to be incremental to and independent of conventional
Framingham designated) CV risk factors (5–8).
Often these 2 methods of estimating personal CV risk are
t odds with each other when individual translations are
isparate and in line when individual translations are in
ccord. Thus, 2 camps are frequently found, one stating that
AC is “no better than risk factors” and the other stating
AC “is better than risk factors.” The answer, in my
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.p
From The Ohio State University, Columbus, Ohio; PrevaHealth, Columbus,
hio; and the Princeton Longevity Center, Princeton, New Jersey.pinion, lies in between, but the more complete translation
or an individual requires improvement.
Research has long shown that ethnic factors both depen-
ent and independent of conventional CV “risk factors” play
n important role for heart attack and stroke risk in the
thnically diverse population of the U.S. Even socio-
conomic factors such as level of primary and secondary
ducation affect long-term CV risk (9). These factors, which
ikely are amplified by genetics, cannot be reflected or
odeled properly into conventional point risk scoring, but
ay be factors already incorporated into baseline CAC
stimates of coronary atherosclerotic plaque burden.
The Framingham risk score was largely (but not exclu-
ively) derived from long-term data on enrollees that were
on-Hispanic whites (NHW). To complicate the matter,
he prognostic information derived from CAC to date, both
s a total score and percentile rank score, was also largely
but not exclusively) derived from long-term data on enroll-
es that were also primarily NHW. If we have this much
onfusion in translation for one major ethnic group, then
heaven help us’ in our attempts to translate these hiero-
lyphics into broad-based ethnic CV risk assessments.
Prior publications on CAC prevalence and scoring from
ifferent ethnic groups in the U.S. have been variable. Our
riginal CARDIA (Coronary Artery Risk Development in
oung Adults study) publication (10) indicated the preva-
ence of any CAC in younger populations was highest in
frican American (AA) men compared with NHW men,
nd that the prevalence of any CAC was higher in AA
omen compared with NHW women. A later publication
rom otherwise healthy and young (age 40 to 45 years)
oldiers refuted these finding, saying that CAC was less
revalent in AA than NHW (11), thus casting confusion
nto the potential value of CAC across ethnic borders. The
allas Heart study, specifically designed to include 50% AA
nd 50% NHW, perhaps put these issues to rest by
alancing the numbers of subjects included. In that publi-
ation (12), the authors found the prevalence of any CAC to
e similar in men and women of both ethnic groups.
mportantly, the absence of CAC (a “zero” score) in this
argely middle-aged population was 62% for AA and 67%
or NHW, which is a bit higher than other broad-based
tudies done in screening populations (50% with zero
cores). The “zero” score has occupied a very important
osition as study after study demonstrated a low-to-very-
ow medium-term (3- to 5-year) CV risk, regardless of
itigating risk factors (5–8).
All these epidemiologic data were, however, difficult to
esolve in terms of CV prognosis or mortality because, in
eneral, AA have a much higher incidence of nonlipid risk
actors including smoking, diabetes, and hypertension; his-
orically, AA have been shown to be at significantly higher
verall CV risk than NHW (13) (and other ethnic groups,
.g., Asians and Hispanics). The critical issue is that prior
rognostic studies looked at either/or for the independent
v
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Editorial Comment September 4, 2007:961–3ariables of risk factors and CAC and did not really consider
he impact on future CV events using both risk factors and
AC.
he Current Investigation
n this issue of the Journal, Nasir et al. (14), representing the
ombined efforts of 5 academic centers, have perhaps given
s a glimpse of the ethnic CV risk Rosetta stone scripting
ata from conventional assessment and plaque imaging
CAC) with regard to long-term all-cause mortality in
nitially asymptomatic individuals.
In the study under discussion, a total of 14,812 individ-
als were initially referred by their primary care physicians
etween 1991 and 2004 for CAC measures using electron-
eam computed tomography (EBT). Conventional risk
actors, along with primary ethnicity, were determined from
atient interview, referring physician contact, and existing
edical records. These individuals were followed for all-
ause mortality over a mean of 6.8 years (range 0.7 to 14.5
ears) through verification via the National Death Index
NDI). The NDI essentially defines mortality as permanent
etirement of an individual’s social security number. Four
isk groups were examined: AA, NHW, Hispanics, and
sians.
The prevalence of a family history of premature disease
nd hyperlipidemia was highest in NHW, whereas the
revalence of smoking, diabetes, hypertension, and female
ender were highest in AA. Coronary artery calcification
cores (as estimates of initial plaque burden) were divided
nto low (0 to 10), mild (11 to 100), moderate (101 to 400),
igh (401 to 1,000), and very high (1,000). The preva-
ence of a low score was 50% in NHW and approximately
0% in AA, Hispanics, and Asians.
Examining all-cause mortality across a decade, a low
alcium score consistently demonstrated a low-to-very-low
ortality rate across all ethnic subgroups (0.2% to 0.5%/
ear), consistent with prior published CV event rates using
AC as the primary variable. However, the all-cause
ortality data were disparate in the presence of mild to very
igh CAC scores when looking at each ethnic subgroup. As
as been shown in prior studies, the higher the CAC score,
he worse the prognosis regardless of ethnicity, but the
nding of mild or more CAC in NHW conferred an
ll-cause mortality of up to one-half that documented for
A, the Hispanics following closely the NHW statistics
ith Asians showing the least all-cause mortality of all
thnicities.
he Rosetta Stone
ow can we “translate” this information into clinical prac-
ice? That is, how do these data help make sense of
onfusing hieroglyphics into understandable Greek? First of
ll, CAC score is proven again to be a powerful discrimi-
ator for individual all-cause mortality and thus CV mor-
ality, regardless of ethnic origin. Additionally, the absencef CAC on EBT scanning described a low-to-very-low risk
roup, independent of conventional risk factors, but what
bout the disparity for all-cause mortality with increasing
AC scores, being greatest in AA and least in Asians?
Coronary artery calcification is an estimator of plaque
urden; the severity of coronary atherosclerosis regardless of
hether it is estimated by the number of stenosed vessels or
xtent of disease by intravascular ultrasound predicts with
ncreasing severity a higher CV event rate, so the findings of
he current investigation are consistent with that principle.
owever, estimates of plaque burden are not necessarily
redictors of plaque instability. The fact that risk factors are
redictive of CV events at all lies in the fact that the greater
he number of potentially inflammatory influences (includ-
ng genetic/family predisposition), the greater the likelihood
f plaque instability, although influenced as shown in the
urrent investigation by the underlying milieu (i.e., the
therosclerotic plaque burden). The findings are reflected in
he higher frequency of no risk factors in the Asians across
thnic subgroups and the higher frequency of 3 risk
actors (almost double that of Asians) in AA.
This principle underlies the SHAPE (Screening for
eart Attack Prevention and Education) paradigm (15) in
hich we advocated estimating the atherosclerotic plaque
urden (using carotid ultrasound and/or CAC scoring) in an
ndividual first followed by a thorough investigation and
herapy of the proinflammatory milieu, guided by the extent
f disease, rather than defining risk factors first (conven-
ional approach) and looking for plaque only if the median
opulation risk is intermediate/indeterminate.
As with all translational research, the current study is but
ne more step in understanding the nature of coronary
therosclerosis and its individual consequences. I look for-
ard to more attempts to unravel the risk factor hieroglyph-
cs into an understandable language applicable to the ex-
anding and complicated kinetics of the American culture.
eprint requests and correspondence: Dr. John A. Rumberger,
rinceton Longevity Center, 136 Main Street, Princeton, New
ersey 08540. E-mail: jrumberger@theplc.net.
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